STREPTOZOTOCIN IN THE TREATMENT OF CANCER: PHASE II STUDY = LA STREPTOZOTOCINE DANS LE TRAITEMENT DU CANCER. ETUDE A LA PHASE IISTOLINSKY DC; SADOFF L; BRAUNWALD J et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 1; PP. 61-67; BIBL. 14REF.Serial Issue

CHEMOTHERAPY IN THE MANAGEMENT OF METASTATIC CANCER OF UNKNOWN PRIMARY SITE = CHIMIOTHERAPIE DES CANCERS METASTATIQUES A LOCALISATION PRIMITIVE INCONNUELLEANDER VC; GOLDSTEIN G; HORSLEY JS III et al.1972; ONCOLOGY; SWITZ.; DA. 1972; VOL. 26; NO 2-3; PP. 265-270; BIBL. 10REF.Serial Issue

THE BACKGROUND AND PROMISE OF TUMOR VIROLOGY, IMMUNOLOGY, AND CHEMOTHERAPY AND A CHALLENGE TO RADIOTHERAPY = FONDEMENTS ET PROMESSES DE LA VIROLOGIE, DE L'IMMUNOLOGIE ET DE LA CHIMIOTHERAPIE TUMORALES, ET UN DEFI LANCE A LA RADIOTHERAPIEGELLHORN A.1973; AMER. J. ROENTGENOL. RADIUM THERAPY NUCL. MED.; U.S.A.; DA. 1973; VOL. 117; NO 3; PP. 489-501; BIBL. 2P.Serial Issue

CLINICAL STUDY WITH BLEOMYCIN: TOLERANCE TO TWICE WEEKLY DOSAGE = ETUDE CLINIQUE DE LA BLEOMYCINE: TOLERANCE A L'ADMINISTRATION 2 FOIS PAR SEMAINEOHNUMA T; SELAWRY OS; HOLLAND JF et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 4; PP. 914-922; BIBL. 15REF.Serial Issue

CONTRIBUTIONS OF SURGEONS TO CLINICAL CANCER CHEMOTHERAPY = CONTRIBUTIONS DES CHIRURGIENS A LA CHIMIOTHERAPIE D'UN CANCER CLINIQUEPATTERSON WB.1972; ONCOLOGY; SWITZ.; DA. 1972; VOL. 26; NO 2-3; PP. 277-286; BIBL. 1P.1/2Serial Issue

BLEOMYCIN, EIN NEUES ANTITUMOR-ANTIBIOTIKUM ZUR BEHANDLUNG NEOPLASTISCHER KRANKHEITEN = LA BLEOMYCINE, UN NOUVEL ANTIBIOTIQUE-ANTITUMORAL DESTINE AU TRAITEMENT DES MALADIES NEOPLASIQUESCHRISTENSEN L.1972; WIEN KLIN. WSCHR.; OESTERR.; DA. 1972; VOL. 84; NO 46; PP. 737-743; BIBL. 2 P.Serial Issue

TOXICITE ET EFFICACITE A COURT TERME DE QUATRE REGIMES DIFFERENTS DE CYTOSINE-ARABINOSIDE DANS 40CAS DE TUMEURS SOLIDES HUMAINESISRAEL L; HAMEL C; GUIBOUT P et al.1972; SEM. HOP.; FR.; DA. 1972; VOL. 48; NO 47; PP. 3093-3097; ABS. ANGL. ESP. ALLEM.; BIBL. 10REF.Serial Issue

RESULTATS D'UNE ETUDE CLINIQUE EN COOPERATION SUR L'ANTIBIOTIQUE ANTITUMORAL DACTINOMYCINETITIEVSKAYA VV; GORBUNOVA VA; AKOPYANTS SM et al.1972; ANTIBIOTIKI; S.S.S.R.; DA. 1972; VOL. 17; NO 10; PP. 953-958; H.T. 1; ABS. ANGL.; BIBL. 16REF.Serial Issue

CLINICAL AND PHARMACOLOGICAL STUDIES WITH 5-HYDROXY-2-FORMYLPYRIDINE THIOSEMICARBAZONEDE CONTI RC; TOFTNESS BR; AGRAWAL KC et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 7; PP. 1455-1462; BIBL. 22REF.Serial Issue

EARLY CLINICAL EXPERIENCE WITH BLEOMYCINE IN THE UNITED KINGDOM IN SERIES OF 105 PATIENTSHALNAN KE; BLEEHEN NM; BREWIN TB et al.1972; BRIT. MED. J.; G.B.; DA. 1972; NO 5841; PP. 635-638; BIBL. 12REF.Serial Issue

SELECTIVE MULTIPHASE CANCER THERAPY: CONCEPTUAL ASPECTS AND EXPERIMENTAL BASISVON ARDENNE M.1972; ADV. PHARMACOL. CHEMOTHERAPY; U.S.A.; DA. 1972; VOL. 10; PP. 339-380; BIBL. 2P.1/2Serial Issue

TRAITEMENT ASSOCIE DES CANCERS PAR IRRADIATION ET LA BLEOMYCINE1972; J. JAP. SOC. CANCER THERAPY; JAP.; DA. 1972; VOL. 7; NO 1; PP. 1-15; ABS. ANGL.; BIBL. 8 REF.Serial Issue

UNTERSUCHUNGEN DES SAEURE-BASEN-HAUSHALTES BEI ZYTOSTATISCHER THERAPIE = ETUDES DE L'EQUILIBRE ACIDO-BASIQUE DANS LE TRAITEMENT CYTOSTATIQUEKUEHBOECK J; KUMMER F.1972; WIEN. Z. IMMERE MED. GRENZGEB.; OESTERR.; DA. 1972; VOL. 53; NO 10; PP. 513-516; ABS. ANGL.; BIBL. 5REF.Serial Issue

IN VIVO HISTOLOGIC STUDIES1971; NATION. CANCER INST. MONOGR.; U.S.A.; DA. 1971; NO 34; PP. 215-238; BIBL. DISSEM.Serial Issue

KLINISCHE ERPROBUNG VON BLEOMYCIN BEI TUMOR-PATIENTEN = ESSAIS CLINIQUES DE LA BLEOMYCINE DANS LES CANCERS HUMAINSRIECHE K; MATTHIAS M.1973; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1973; VOL. 41; NO 3; PP. 232-240; ABS. ANGL.; BIBL. 16REF.Serial Issue

ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS. II. THERAPEUTIC USES = MEDICAMENTS ANTINEOPLASIQUES ET IMMUNODEPRESSEURS. II. INDICATIONS THERAPEUTIQUESCRIDLAND MD.1972; DRUGS; SWITZ.; DA. 1972; VOL. 3; NO 5-6; PP. 331-351; BIBL. 3P.1/2Serial Issue

FURTHER CLINICAL TRIALS WITH PORFIROMYCIN (NSC-56410) (LARGE INTERMITTENT DOSES)IZBICKI R; MUHYI AL SARRAF; REED ML et al.sdCANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 197; VOL. 56; NO 5; PP. 615-624; BIBL. 3REF.Serial Issue

OPTIMAL ANTIBIOTIC THERAPY INFECTIONS IN PATIENTS WITH CANCER. PROSPECTS FOR THE FUTURE = CHIMIOTHERAPIE OPTIMALE PAR LES ANTIBIOTIQUES POUR LE TRAITEMENT D'INFECTIONS DE MALADES CANCEREUX. PERSPECTIVE D'AVENIRKLASTERSKY J; STAQUET M.1973; EUROP. J. CANCER; G.B.; DA. 1973; VOL. 9; NO 6; PP. 397-399; BIBL. 9REF.; (E.O.R.T.C. SYMP. OPTIM. ANTIMICROB. THER. PATIENTS CANCER; BRUXELLES; 1973)Conference Paper

INFECTIONS IN CANCER PATIENTS. RESULTS WITH GENTAMICIN SULFATE THERAPY = LES INFECTIONS CHEZ LES CANCEREUX. RESULTATS DU TRAITEMENT PAR LE SULFATE DE GENTAMYCINEBODEY GP; MIDDLEMAN E; UMSAWADI T et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 29; NO 6; PP. 1697-1701; BIBL. 14REF.Serial Issue

PRELIMINARY CLINICAL EXPERIENCE WITH CIS-DIAMMINEDICHLOROPLATINUM (II) (NSC 119875, CACP)ROSSOF AH; SLAYTON RE; PERLIA CP et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1451-1456; BIBL. 21 REF.Serial Issue

STREPTOZOTOCIN TREATMENT OF METASTATIC CARCINOID TUMORS = TRAITEMENT A LA STREPTOZOTOCINE DES TUMEURS CARCINOIDES METASTATIQUESFELDMAN JM; QUICKEL KE JR; MARECEK RL et al.1972; SOUTH. MED. J.; U.S.A.; DA. 1972; VOL. 65; NO 11; PP. 1325-1327; BIBL. 8 REF.Serial Issue

SURGICAL CHEMOTHERAPY FOR TREATMENT OF EXPERIMENTAL TUMORS (ANIMALS) AND FOR ADVANCED TUMORS (HUMANS) = LA CHIMIOTHERAPIE CHIRURGICALE DANS LE TRAITEMENT DE TUMEURS EXPERIMENTALES (ANIMALES) ET DE TUMEURS (HUMAINES) TRES EVOLUEESGARAS J; NIKOLAIDES G; RAMANTANIS G et al.1972; INTERNATION. SURG.; U.S.A.; DA. 1972; VOL. 57; NO 8; PP. 654-657; ABS. ESP. ALLEM. ITAL. FR.Serial Issue

CANCER CHEMOTHERAPY. I. METHODS, AGENTS AND OVERALL RESULTS IN 400 PATIENTS = CHIMIOTHERAPIE ANTICANCEREUSE. I. METHODES, AGENTS ET RESULTATS CHEZ 400MALADESHILL GJ; LARSEN RR.1972; ONCOLOGY; SWITZ.; DA. 1972; VOL. 26; NO 2-3; PP. 206-222; BIBL. 1P.1/2Serial Issue

BLEOMYCIN, AN ANTITUMOR ANTIBIOTIC. CLINICAL EXPERIENCE IN 274PATIENTSYAGODA A; MUKHERJI B; YOUNG C et al.1972; ANN. INTERN. MED.; U.S.A.; DA. 1972; VOL. 77; NO 6; PP. 861-870; BIBL. 20REF.Serial Issue

PHASE II EVALUATION OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN PATIENTS WITH SOLID TUMORSRAMIREZ G; WILSON W; GRAGE T et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 787-790; BIBL. 13REF.Serial Issue